Diana Gershtein, M.Sc, MBA

Cell Therapy Section Manager

Ms. Gershtein holds a Bachelor's degree (BSc) in Biology from the Technion – Israel Institute of Technology, and Master's degrees in Biology (MSc) and Business Administration (Executive MBA) from Haifa University, Israel.

Diana has 14 years of diversified experience in the Advanced Therapies industry (cell and gene therapy, regenerative medicine) with a vast knowledge in Regulatory Affairs, development, pre-clinical and clinical studies design, GMP manufacturing and Quality Assurance.

At her former position at MultiGene Vascular Systems (MGVS), Diana has overseen clinical cell therapy product manufacturing in Israel and USA, established quality system suitable for multi-center clinical manufacturing, developed operational and logistics programs for advanced-phase clinical studies and played a key role in regulatory affairs with the FDA and EMA.

Within her framework at Gsap, Ms. Gershtein serves as the Cell Therapy Section Manager. Gsap has worked until today with more than 25 cell therapy and gene therapy companies/products in Israel and abroad, at different stages of product development, starting from early proof of concept, through pre-clinical and clinical stages.

During her work in Gsap Diana lead projects in the following companies: Pluristem Therapeutics, Kadimastem, Bonus BioGroup, CellCure Neurosciences, Sheltagen, Betalin, BioGenCell, Accelta, Immuno-Therapy laboratory (Tel Aviv Sourasky Medical Center), Cytora, Brainstorm, CTG, Exostem, KidneyCure, Monovia Therapeutics, BM transplantation unit at Tel Aviv Sourasky Medical Center, Precise Bio, AVROBIO and CAR-T cells units at Tel-ha-Shomer, Tel Aviv Sourasky and Hadassah Medical Centers). 

Creativity is a natural extension of our enthusiasm
Earl Nightingale